Insurance by BogdanovaThe Encyclopedia of Insurance and Risk Science

RESEARCH DOSSIER

Cognitive Decline Trajectories and Claims Risk Measurement

Abstract. Cognitive decline becomes an insurance liability through a succession of empirically distinguishable events: change in cognition, change in practical functioning, need for assistance or supervision, satisfaction of a contractual or statutory benefit trigger, claim admission, and payment during an eligible duration. This Research Dossier investigates how longitudinal cognitive trajectories should be related to long-term care, disability, health, and public care entitlements without treating a clinical test, diagnosis, care episode, and insured claim as interchangeable measures. It synthesizes original prospective cohort evidence, functional assessment research, primary benefit rules in the United States, Germany, and the United Kingdom, and actuarial experience-study definitions. A continuous-time multistate formulation makes explicit entry, reversion or reassessment, death as a competing event, claims termination, exposure, payments, and discounted liability. A reproducible hypothetical numerical example demonstrates how materially different future cash flows can arise from the same baseline population when transition or mortality assumptions change. The analysis identifies measurement and selection biases, incomplete diagnosis coding, interval censoring, missing follow-up, shifting assessment standards, and contractual heterogeneity as principal threats to transportability. The substantive result is an operational research distinction between cognitive prognosis and claims prognosis: actuarial inference requires joint information about cognition, dependency, contract design, exposure, adjudication, and payment behavior. The contribution is an original evidence-based synthesis and transparent calculation, without a claim to a new theory, novel empirical dataset, or externally validated pricing model.

Keywords: Cognitive decline; dementia; mild cognitive impairment; long-term care insurance; disability insurance; claims incidence; claims termination; activities of daily living; supervision; multistate models; competing risks; functional dependency; actuarial reserving; longitudinal measurement; evidence verification.

Introduction

The actuarial object of this study is the distribution of covered future claims and claim payments associated with cognitive and functional change. A cognitive trajectory is a time-indexed series of measurements or latent functional states; a claim is a contractual or programmatic event established by an applicable eligibility rule; a payment is a financial outflow conditional on administrative and coverage conditions. Every empirical comparison must state which of these quantities its numerator describes and which population remains at risk in the denominator.

The WHO International Classification of Functioning (WHO, 2001) gives an explicit framework for functioning, activity, participation, and environment. The framework is essential because the same cognitive limitation can produce different actual assistance needs depending on housing, aids, caregivers, social organization, and concurrent physical disability. The WHO dementia status report (WHO, 2021) documents why dementia care extends across health, social support, households, and public systems. Consequently, disability or care expenditure does not measure neuropathology alone.

The relevant literature comes from several traditions. Clinical criteria establish when cognitive syndromes are recognized; longitudinal cohorts reconstruct the temporal path toward diagnostic thresholds; functional instruments describe dependence; public statutes and private policies specify benefit triggers; and actuarial data define insured incidence, exposure, and termination. These traditions often observe different denominators and different clocks. A population study can observe scores years before dementia diagnosis; an insurance file may begin only at policy issue and register a claim after assessment and an elimination period. A comparison that ignores these origins confounds disease development, insured selection, contract architecture, and reporting delay.

The central questions are therefore: which observed changes forecast a need for supervision; how does that need map into covered entitlement; how are states and transitions estimated when claim and clinical records observe different parts of the path; and how do these distinctions affect frequency, duration, reserves, and comparisons across populations? The following six chapters answer these questions using verified published evidence and explicit model assumptions. They do not estimate rates from proprietary insurer microdata, make individual clinical predictions, or represent an insurance product design.

Conceptual Foundations and Historical Development

A chain of scientific and contractual definitions

Clinical cognitive impairment describes measurable difficulties in domains such as memory, executive function, attention, language, and spatial orientation. Mild cognitive impairment (MCI) occupies an intermediate clinical classification in many research traditions; a person may show objective impairment while preserving substantial functional independence. The National Institute on Aging–Alzheimer's Association MCI clinical recommendations (Albert et al., 2011) separate symptomatic predementia criteria from stronger biomarker-based research classifications. The dementia diagnostic recommendations (McKhann et al., 2011) address dementia due to Alzheimer disease and emphasize clinical evaluation. Neither set is itself a private policy's coverage definition.

Functioning introduces a second axis. Lawton and Brody's instrumental daily-living assessment (1969) studies self-maintaining and instrumental activities of daily living. Instrumental activities, such as managing finances or medications, may become difficult before basic personal care. Cognitive impairment, instrumental limitations, assistance with basic activities, continual supervision for safety, and institutional residence are analytically separate states. A patient can require supervision while being physically able to bathe and dress; a person can have multiple physical ADL limitations while cognitive tests remain relatively preserved.

A public or private insurer observes a third axis: the rules defining entitlement. Under the U.S. Internal Revenue Service's qualified long-term care description (IRS, 2025), a chronically ill individual may qualify through substantial assistance with at least two specified ADLs for at least 90 days, or through substantial supervision needed because of severe cognitive impairment, subject to the relevant certification conditions. The cognitive-supervision route is structurally distinct from the two-ADL route. Actual policy terms and claims evidence determine the right to private benefits; an IRS definition associated with tax qualification does not replace the entire insurance contract.

The National Association of Insurance Commissioners' long-term care shopper's guide (NAIC, 2019) explains cognitive impairment and ADLs as triggers, along with elimination periods, covered settings, and policy-specific payment terms. It is an educational regulatory publication, not an enacted uniform insurance law. Its practical implication is immediate: a clinical diagnosis may precede entitlement, and entitlement may precede the first covered benefit day. Some claims are eligible but unpaid during the waiting interval; other cases reflect uncovered services, exclusions, exhausted benefits, or absent submission.

Historical development of measurement

The intellectual sequence proceeded from basic and instrumental functional instruments toward structured dementia ratings, repeated cohort measurement, and modern actuarial experience datasets. Morris's Clinical Dementia Rating rules (1993) represent clinician-rated staging; the Minimum Data Set Cognitive Performance Scale (Morris et al., 1994) derives structured cognitive categories from nursing-home assessment items. Nasreddine and colleagues' Montreal Cognitive Assessment study (2005) introduced a screening instrument aimed at detecting MCI. These instruments answer different questions and can have different observable ranges, norms, licensing or administration rules, and error structures. A score from one cannot be silently substituted for another or for a contract's supervision trigger.

A contemporary actuarial milestone is the SOA Long-Term Care Experience Committee's 2000–2016 intercompany study (SOA, 2020). The report distinguishes claim-incidence and claim-termination files, documents how exposures are calculated, and describes aggregation constraints imposed on release of policy-level information. It aggregated inputs from 18 companies representing approximately 80% of 2016 LTC earned premium. This is evidence about the contributing insured portfolios and definitions, with its own selection and reporting boundaries, rather than a population-wide clinical incidence curve.

Research units and temporal origins

A defensible data dictionary distinguishes at least five dates: policy entry, first observed cognitive difficulty, first sustained need for eligible assistance, claim notification or admission, and first payment. Additional dates include diagnosis, reassessment, benefit exhaustion, recovery or loss of eligibility, death, and policy lapse. Some are intrinsically latent and only known to lie between assessments. A date in a file is therefore an observation about a particular process, not automatically the onset of a biological state.

Let the observed clinical sequence for person i be Y_i(t_1),...,Y_i(t_m), the latent cognition or dependency path be C_i(t), policy terms be P_i, supervision and functional need be F_i(t), adjudicated eligibility be E_i(t), and payments be B_i(t). The forecast object for an insurer is the conditional distribution of discounted B_i(t) given exposure and available information. The forecast for a public program may instead involve service utilization and co-financing. The difference arises from the benefit rule and financing institution, not from a universal medical threshold.

Cognitive Trajectory Models

Longitudinal evidence and heterogeneity

A single linear decline is an inadequate general description of all older adults. In the Rotterdam cohort, Verlinden and colleagues' preclinical functioning trajectories (2016) compared 856 dementia cases and 1,712 controls across repeated measurements. Memory complaints, cognitive scores, instrumental daily functioning, and basic daily functioning showed differing temporal sequences. Their evidence concerns group patterns aligned to eventual dementia diagnosis; it does not identify the date of an insurance benefit trigger.

In a U.S. prospective cohort of 4,315 participants, Li and colleagues' 20-year cognitive trajectory analysis (2017) reported average cognitive decline detectable at least a decade before dementia diagnosis, with an estimated acceleration about three years before clinical diagnosis in those subsequently diagnosed. In Sweden, Payton and colleagues' 12-year longitudinal study (2023) related trajectories across cognitive tests to later dementia: rapid decline in three or more tests over an earlier six-year window was associated with later dementia (reported hazard ratio 3.90, 95% confidence interval 2.28–6.69). The first study's change point and the second study's hazard ratio describe distinct estimands, populations, instruments, time origins, and adjustments; neither is a claim incidence rate or an individual prediction probability.

MCI may remain stable, appear to revert, or progress in subsequent assessments. Salemme and colleagues' MCI prognosis meta-analysis (2025) combined 89 studies with mean follow-up 5.2 years. Reported conversion to dementia was 41.5% for clinical cohorts and 27.0% for population samples; reported reversion was 8.7% and 28.2%, respectively. These percentages reflect cumulative study-specific classifications over varying observation periods. They cannot be converted into constant annual transition intensities by simple division, nor interpreted as biological reversal whenever an observed category improves. Referral selection, diagnostic thresholds, attrition, and regression to the mean contribute to the differences.

A nursing-home assessment population supplies another contrast. Morris and colleagues' CogRisk-NH longitudinal analysis (2023) used U.S. and Canadian interRAI data from more than 1.25 million resident assessment sequences, distinguishing baseline cognitive severity and future change. The baseline residence and repeated quarterly assessment design select a much more impaired risk set than community cohorts or newly underwritten policyholders. Its reported risk gradients may help stratify care workloads, but claims projection additionally requires insured eligibility, payment rules, and termination experience.

What is observed and what is latent

An observed score is a noisy, instrument-specific measurement of cognition and task performance, shaped by education, language, health, sensory deficits, practice effects, mood, medication, and testing context. Denote the measured score by

[ Y_{ij}=m(t_{ij},X_i,b_i)+\varepsilon_{ij}, ]

where X_i are observed characteristics, b_i represent person-specific differences, and the measurement-error distribution depends on the instrument and setting. A flexible mean function m may include time splines, age, calendar cohort, and interactions. Random slopes describe variation in trajectories; a time-to-diagnosis alignment describes a retrospective clinical history conditioned on eventual diagnosis and should not be mistaken for a forward prediction model in all insured lives.

The latent process can be discrete or continuous. A continuous trait model preserves score gradients, while a clinically classified multistate model defines normal cognition, MCI, dementia, and death. An insurance state system adds eligible supervision, claim admission, benefit payment, and contractual termination. Two persons with the same test score may occupy distinct claims states because of environmental risk, policy triggers, competing physical disability, caregiver arrangements, or documentation. Thus, the mapping from latent cognition C_i(t) to observed claim Q_i(t) is conditional on functional needs, policy terms, and institutional administration.

Selection, time scales, and classification change

Time since policy issue, attained age, time since diagnosis, time since care need, and calendar time answer different questions. Entry at issue creates insured selection; entry at first clinical visit creates care-seeking selection; entry on a paid claim conditions on claims approval and survival through the waiting period. Left truncation is needed when people become observable after the process has started. When measurements occur only annually or biennially, the exact crossing time of a threshold is interval-censored. Death before a scheduled visit reduces observable cognitive measurements; a complete-case trajectory can consequently describe the survivors rather than the original risk set.

The central transportability question is whether the relationship between measured cognition and qualifying care need remains stable across age, cohort, language, instrument, product, and delivery system. The answer requires a bridge study observing both clinical and contractual states. Transporting a cohort hazard ratio directly to claims frequency assumes identical event definition, risk set, testing process, selection, and censoring; those assumptions seldom hold without evidence.

Supervision and Eligibility Measurement

Functional dependency as the intermediate state

The primary insurance-relevant consequences of declining cognition include impaired judgment of hazards, wandering or disorientation, difficulty following medication regimens, inability to organize meals or money, behavioral distress, and a need for someone to be present to prevent harm. Functional and environmental adaptation can change the amount of human assistance needed even when underlying cognitive scores are relatively unchanged. The WHO's ICF classification framework (WHO, 2001) makes environmental context part of functioning rather than a residual nuisance variable. Operational measurement must record both capability and the actual support environment.

Under U.S. tax-qualified LTC definitions, the cognitively impaired person may satisfy a supervision trigger even while basic ADLs remain largely intact. The IRS qualified-care criteria (IRS, 2025) require a practitioner certification within the relevant period and distinguish inability to perform two of six defined ADLs for at least 90 days from the need for substantial supervision arising from severe cognitive impairment. The certification should be matched to the dated observation that supports it. For actuarial analysis, an eligible person who has not requested benefits and an admitted claimant who has not yet received payment should remain separate observations.

The NAIC's benefit trigger and waiting-period guide (2019) describes variation in how private products assess and pay. Elimination periods, home-care coverage, allowable providers, maximum daily amounts, aggregate benefit pools, coordination provisions, and inflation terms can alter payments after a trigger is satisfied. Therefore, a claim file's first paid date is often a later event than the date at which health-related dependence arose. A research audit must preserve both dates where possible and code the reason for a gap.

Comparative institutional measurement

Germany's statutory long-term care insurance illustrates a multidimensional assessment. SGB XI section 14 defines need for long-term care with reference to health-related impairments of independence or abilities, including physical, cognitive, and psychological limitations, anticipated to last at least six months and meeting the statutory severity threshold. SGB XI section 15 establishes the assessment instrument and care grades. Its weighted modules include mobility; cognition and communication or behavioral and psychological problems; self-care; health-related demands; and structuring daily life and social contacts. The combined cognition/behavior component has 15% weight, and self-care has 40% weight under the statutory formula. The official scoring annex details the point transformations. These are statutory system parameters, not directly transferable coefficients for a U.S. private policy.

The United Kingdom provides a different supervision-oriented comparison. Section 64 of the Social Security Contributions and Benefits Act (1992, as amended at the cited consolidation date) connects Attendance Allowance to qualifying day or night attention and supervision needs, among other requirements. The current administrative claim form (Department for Work and Pensions, 2025) seeks details of everyday help, guidance, encouragement, and supervision. A British public-benefit assessment cannot be equated numerically with a German Pflegegrad or the private U.S. cognitive-supervision trigger. The programs differ in entitlement populations, statutory time requirements, evidence instruments, benefit structures, and adjudication.

These three examples support a central comparative result: equal observed cognitive severity can generate different insured or publicly financed claims because the systems operationalize dependency differently. A standardized comparison can report multiple estimands side by side: impairment prevalence; functional-supervision prevalence; prevalence of meeting each benefit rule; approved claims per exposed life-year; and payments per claim-year. Even these require harmonized age and enrollment definitions before geographic interpretation.

Observation error and proxy reports

Assessment systems rarely have identical sensitivity for early executive impairment, changing behavior, and inability to carry out instrumental tasks. An apparently unchanged score may coincide with sharply increasing caregiver burden. A diagnosis recorded in administrative claims depends on clinical access, coding practices, and incentives. Conversely, an administrative flag can persist after a clinical reassessment. The NHATS agreement study (2024) compared subjective cognitive impairment with a validated probable dementia algorithm and documented classification disagreement, including differences by age and education. It establishes the need to specify a reference definition and quantify classification error; it does not validate an insurer's individual claim decision.

A usable adjudication research dataset should include assessor type, instrument/version, informant availability, date of testing, prior scores, ADL and instrumental ADL status, observed supervision tasks, safety incidents, service location, comorbid illness, caregiver presence, and the applicable policy edition. It should also distinguish a self-report, proxy report, clinician record, and insurer decision. Agreement studies should estimate sensitivity, specificity, and positive predictive value at the prevalence and eligibility threshold of the target portfolio, because a classifier developed in a high-prevalence nursing-home sample may exhibit a much lower positive predictive value in a healthier insured cohort.

A measurement illustration

Consider two hypothetical people who both score below the same cognitive screening threshold. Person A continues to manage daily life safely with compensatory tools and no required substantial supervision. Person B has disorientation episodes and needs an adult present to avoid substantial danger. A clinical score threshold flags both for further assessment, but a U.S. private policy using the qualifying cognitive-supervision language may treat them differently. Conversely, a third person with two qualifying physical ADL limitations may meet a separate trigger without severe cognitive impairment. This is a logical application of the IRS definition of chronic illness, not a clinical judgment or coverage decision about real individuals.

For population analysis, let the observable screening indicator be Z and the contractual eligibility state be E. The quantity P(E=1 | Z=1) depends on target-population prevalence, assessment practice, and benefit text; it cannot be read from P(Z=1 | eventual dementia). A design that records only Z leaves a potentially large and structured eligibility misclassification error. Data collection priorities follow directly from this algebra.

Claims Onset and Progression

Incidence, termination, and the risk set

Claims onset must be defined with a counting rule: first qualifying entitlement, first notified claim, first approved claim, or first paid claim. If N(t) counts first paid claims and Y(t) is exposed, in-force, claim-free policy time, a cause-specific observed incidence estimate may be written as dN(t)/Y(t) over a small interval or as total claims divided by exposure years in an appropriately stratified interval. The risk set excludes already-on-claim lives for first-claim incidence; an all-policy denominator without adjustment mechanically understates the specified rate. Each rate also depends on issue age, attained age, duration, underwriting class, calendar period, policy form, elimination period, and benefit scope.

A terminating claim can end through death, qualifying recovery, administrative closure, expiry of the benefit maximum, lapse of coverage, transfer, or other contract-specific causes. An observed termination rate is therefore not necessarily a recovery rate. The SOA's LTC aggregate experience methodology (2020) explicitly separates incidence from termination data. The 2025 LTC data request specifies incidence, termination, and utilization for 2000–2023 stand-alone LTC contracts while excluding combination and acceleration products from the planned scope. The announcement and request establish a research program; they do not themselves supply independently estimated final 2000–2023 termination tables.

Long-term disability (LTD) experience is related but requires a separate endpoint. The SOA's 2015–2024 group LTD study (2026) reports contributions from 18 companies and describes recovery and death termination experience for group disability claims. It is relevant to the distinction between return-to-work/recovery and death, but its broad disability terminations must not be relabeled as cognitive-specific long-term care claim outcomes. Disability policies can define occupational incapacity, offsets, and termination ages wholly differently from LTC contracts.

A multistate actuarial specification

For transparent analysis, define a minimal four-state continuous-time process, conditional on being insured and observed: H = no clinically classified impairment sufficient to enter the next state, M = observed cognitive impairment without current LTC benefit eligibility, E = qualifying and modeled payable LTC claim, D = death. D is absorbing. H may transition to M or D. M may return to H through reassessment or functional improvement, progress to E, or die. E may cease to be eligible and enter M or terminate through death. Reentry from M to E is permitted. This is a deliberately simplified illustrative specification; real contracts additionally need stages for policy lapse, waiting periods, claim notification, institutional transfer, benefit exhaustion, and more granular functional states.

For small dt, q_ab(t, x) dt approximates the conditional probability of moving from state a to b while in a at time t, given characteristics x, with diagonal q_aa = -sum_{b≠a} q_ab. Write Q(t,x) for the intensity matrix. When Q is time homogeneous, the state occupation probabilities follow P(t)=exp(Qt). With calendar-time and covariate dependence, a product integral or time-ordered numerical solution replaces the simple matrix exponential. The Putter–Fiocco–Geskus tutorial (2007) explains how competing risks and multistate models connect event-specific hazards and state probabilities.

The benefit forecast is a function of time in state E and of actual payment rules. For continuous payments with annualized eligible-state benefit b(t) and discount force δ(t), an illustrative pre-tax prospective value at time zero is

[ V_0=\int_0^T\exp{-\int_0^t\delta(s),ds},\Pr[X(t)=E\mid X(0)=H],b(t),dt. ]

This expression counts expected benefit payments only. Actual contract liabilities may require premiums, expenses, guarantees, inflation, taxes, risk adjustment, acquisition cash flows, policyholder options, and other covered transitions. For discrete monthly benefits, sum discount factors times expected monthly payments instead. A duration-based or semi-Markov model is needed when termination depends on time already spent on claim, as often occurs in disability experience.

The cumulative probability of first entry into E before death is distinct from the prevalence P(X(t)=E). A claimant can enter and leave E more than once; the probability of having ever claimed can therefore exceed the proportion occupying E at any given time. Similarly, counting death as simple right censoring in a naïve claim-incidence Kaplan–Meier construction can exaggerate the cumulative incidence of a claim event when death precludes first claim. A competing-risk cumulative incidence or Aalen–Johansen construction uses both event types and the at-risk process, as set out by Putter and colleagues (2007).

Fully specified hypothetical calculation

Take 10,000 independent, initially in-force lives, all starting in state H at time zero, with no lapses, no new business, no time variation, no inflation, and no claim-related expenses. All transition intensities below are invented numerical assumptions for a reproducible mathematical example, not estimated U.S., German, British, or insurer probabilities. Time is measured in years. The order of states is H, M, E, D, and the annual intensity matrix is

[ Q=\begin{pmatrix} -0.08 & 0.06 & 0 & 0.02\ 0.03 & -0.19 & 0.12 & 0.04\ 0 & 0.05 & -0.20 & 0.15\ 0 & 0 & 0 & 0 \end{pmatrix}. ]

Rows sum to zero and off-diagonal rates are nonnegative. Thus the model is a valid finite-state continuous-time Markov chain. Benefits are paid only while in E at a constant annualized rate of $36,000, with continuous discount force 3% and five-year horizon. Exact state probabilities are computed from the first row of exp(Qt), rather than by substituting annual probabilities directly for instantaneous intensities.

Time after issue H M E (eligible paid state) D
0 years 1.000000 0.000000 0.000000 0.000000
1 year 0.923918 0.052516 0.003081 0.020485
2 years 0.855005 0.092247 0.010569 0.042179
3 years 0.792384 0.121921 0.020434 0.065261
5 years 0.683161 0.159183 0.042154 0.115502

Numerical quadrature gives a five-year expected discounted benefit value of approximately $2,765.88 per initially covered life, or $27.659 million for the 10,000-life illustration. This is a conditional example of expected payments rather than a premium or regulatory reserve. When only the annual M-to-E intensity rises from 0.12 to 0.18 (with its row diagonal rebalanced from -0.19 to -0.25), the five-year value is approximately $3,889.80 per life, a 40.63% increase. When instead E-to-death rises from 0.15 to 0.20 (with E's diagonal adjusted from -0.20 to -0.25), the value is approximately $2,615.41 per life, a 5.44% decrease. In each scenario the initial population, benefit and discount assumptions are unchanged. This illustrates competing effects of claims entry and claim duration; it makes no inference about real mortality or treatment policy.

The calculation is reproducible with any numerical linear-algebra system using expm(Q*t) and one-dimensional quadrature of 36000*exp(-0.03*t)*P_HE(t) for t from 0 to 5. The empirical task is then to estimate the intensities with appropriate risk sets, covariates, competing events, and contractual data rather than to adopt these illustrative rates.

Payment layers and reserves

A realistic claims liability partitions future payments into eligibility probability, care setting, utilization rate, covered units, price per unit, maximum benefits, cost sharing, benefit escalation, and claim administration. A domiciliary care hour, a nursing-home day, and an indemnity benefit may have different payment curves for the same dependence state. Contract words establish the covered event; claims practice establishes which events are recorded; accounting rules establish recognition of liabilities.

The IFRS Foundation's IFRS 17 requirements describe probability-weighted, discounted fulfilment cash flows and a risk adjustment for nonfinancial risk, among other components of insurance contract measurement. The IFRS 17 definitions of liabilities differentiate liabilities for remaining coverage and incurred claims. A cognitive-claims model may support underlying cash-flow estimation, but the illustrative expected-payment value above is not an IFRS 17 balance-sheet measurement and does not replace financial reporting judgments or jurisdiction-specific solvency rules.

Integrated Findings and Research Agenda

Integrated interpretation

The evidence yields five linked findings. First, cognitive change begins on a continuum and may precede recognized disability by years; temporal associations reported by Li et al. (2017) and Verlinden et al. (2016) reflect long observational histories. Second, the diagnostic path is heterogeneous, with classification stability and reversion that vary by setting, as summarized in Salemme et al. (2025). Third, practical care need is mediated by functional tasks, safety, environment, and support. Fourth, insured claims depend on contract wording and eligibility assessment, so incidence dates and rates are institution-specific. Fifth, death, claim termination, and payment duration jointly determine reserve-relevant cash flows: the illustrative matrix calculation shows that altering only one transition can change expected five-year benefits materially.

These findings imply an identifiable research sequence. A valid clinical-to-claims analysis first establishes the clinical instrument and population, next maps actual functional needs, then codifies each product's contractual trigger, observes the adjudication process, calculates entry and termination using correct exposure, and finally forecasts covered cash flows. The steps can be linked statistically, but a cohort-to-insurer transfer is admissible only with explicit adjustment and validation. This is an analytical protocol derived from ordinary scientific methods and the cited sources, not an independently named doctrine.

Priority questions for future original datasets

The most consequential missing study is a linked prospective dataset that observes cognitive testing, functional supervision, care episodes, actual private policy terms, claim notification, eligibility decisions, and financial payments in the same covered individuals. Such a study could distinguish the latent onset of dependence from recognition and payment delay. In jurisdictions with linked public health and social-care records, the target should similarly distinguish assessment scores from actual entitlements and service intensity. The study protocol should preregister event definitions, follow-up windows, competing events, and validation cohorts, while managing privacy and consent.

A second priority is causal identification of how access to caregiver support and assistive technologies changes eligible supervision, independent of cognitive pathology. A third is claims-state transport across product generations and countries. A fourth is measuring the separate contribution of dementia, mixed neurodegenerative and vascular conditions, physical comorbidity, and frailty to claim duration. A fifth is adjudication fairness: one must test whether comparable documented dependence is associated with different approval latency or payment access across subgroups, accounting for actual contract differences and selection.

The SOA's 2025 industry study announcement notes a planned update to LTC claim experience, while its historical aggregate method report supplies an established exposure and privacy baseline. When new experience tables are published, their exact exposures, data fields, company participation, and product inclusion rules should be compared to the historic study before parameter updates. Updating an existing projection based merely on a later press release would be scientifically unjustified.

A comparative reporting standard for research use

A reproducible scientific result should report, at minimum, its observational population and entry rule; cognitive instrument and repeated-measure schedule; functional and supervision construct; policy or statutory text version; event and claims-date definition; competing mortality and lapses; benefit waiting and payment provisions; numerator and denominator exposure units; model equations; statistical uncertainty; and transferability conditions. It should separate observed cohort rates, fitted parameters, actuarial scenario choices, and approved legal classifications in the results tables. The formal discipline of these disclosures is what permits another researcher to challenge, reproduce, or adapt the analysis.

Conclusion

Cognitive decline trajectories are relevant to insurance because changing cognition can alter dependence, supervision needs, service utilization, and survival. The insurance event, however, is established within a particular contract or public program. Measured impairment, diagnosed dementia, need for help, qualifying supervision, admitted claims, and actual payments form connected but distinct empirical processes. Each requires its own state definition, exposure, observation date, and evidence.

Longitudinal research demonstrates substantial heterogeneity in the timing and direction of cognitive classifications, with marked differences between clinical and population cohorts and between cognitive and practical functioning measures. Primary legal documents show that American tax-qualified LTC supervision, German care grades, and British attendance entitlement implement different observable conditions. Actuarial experience studies likewise distinguish claims entry and termination and are conditioned on the contributing insurance portfolios. A multistate, competing-risk framework joins these findings while preserving their boundaries; projected payments additionally depend on benefits, durations, care utilization, and discounting.

The original contribution of this monograph is the integrated source-critical interpretation, explicit event ontology for measurement, auditable legal comparison, and fully specified mathematical illustration. The calculation confirms that changing progression or claim-state mortality assumptions can materially change expected benefit values even with the same initial exposure. The final scientific conclusion is therefore operational: credible claims risk measurement requires clinical trajectories to be linked to functional need, applicable entitlement, exposure, adjudication, and financial payment records. Future advances depend on longitudinal linkage and reproducible validation, rather than on assigning a single probability of dementia to an insured claim.

References